Dr. Gordon Moran, MD
Claim this profileNottingham University Hospitals NHS Trust and University of Nottingham
More about Gordon Moran, MD
Clinical Trial Related
8 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical Trials
Treatments Gordon Moran, MD has experience with
- 5-ASA Withdrawal
- Treatment Algorithm A
- Treatment Algorithm B
- Treatment Algorithm C
Breakdown of trials Gordon Moran, MD has run
Crohn's Disease
Ulcerative Colitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gordon Moran, MD specialize in?
Gordon Moran, MD focuses on Crohn's Disease and Remission. In particular, much of their work with Crohn's Disease has involved treating patients, or patients who are undergoing treatment.
Is Gordon Moran, MD currently recruiting for clinical trials?
No, Gordon Moran, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Gordon Moran, MD has studied deeply?
Yes, Gordon Moran, MD has studied treatments such as 5-ASA Withdrawal, Treatment Algorithm A, Treatment Algorithm B.
What is the best way to schedule an appointment with Gordon Moran, MD?
Apply for one of the trials that Gordon Moran, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.